Results 151 to 157 of about 5,298,587 (157)

Clinical Summary of Fibroblast Activation Protein Inhibitor-Based Radiopharmaceuticals: Cancer and Beyond

European Journal of Nuclear Medicine and Molecular Imaging, 2022
Xiaoli Lan, Yongxue Zhang, Weibo Cai
exaly  

FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Disease

Radiology, 2023
Jens Cardinale, Clemens Kratochwil, Yuriko Mori   +2 more
exaly  

Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the 68Ga- and 177Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi)2

Molecules
Frank Rösch, Axel Rominger, Ali Afshar-Oromieh   +2 more
exaly  

Beyond Cancer: The Role of Radiolabeled Fibroblast Activation Protein Inhibitors (FAPI) in Non-Oncological Molecular Imaging

Academic Radiology
Narges Jokar, Esmail Jafari, Majid Assadi   +2 more
exaly  

Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a 68Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04

Journal of Nuclear Medicine, 2019
Christian Weber, Sarajo K Mohanta, Zohreh Varasteh   +2 more
exaly  

Experimental Approaches Toward Histone Acetyltransferase Inhibitors as Therapeutics

Medical Epigenetics, 2016
exaly  

Fibroblast Activation Protein Is Overexpressed on Both Stromal and Epithelial Cells Before Pancreatic Ductal Adenocarcinoma: Implications for Early Diagnosis on 68Ga-FAPI-PET/CT

Gastroenterology
Anthony Gill, David Cavallucci, William McGahan   +2 more
exaly